Dual use of Diff-Quik-like stains for the simultaneous evaluation of human sperm morphology and chromatin status by Sousa, Ana Paula M. et al.
...........................................................................................................................
ORIGINAL ARTICLE Andrology
Dual use of Diff-Quik-like stains for the
simultaneous evaluation of human
sperm morphology and chromatin
status
Ana Paula M. Sousa1†, Renata S. Tavares1†,
Juan Felipe Velez de la Calle3, Helena Figueiredo4, Vasco Almeida5,
Teresa Almeida-Santos2, and Joa˜o Ramalho-Santos1,2,6
1Center for Neuroscience and Cell Biology, Department of Zoology, University of Coimbra, 3004-517 Coimbra, Portugal 2Department of
Maternal-Fetal Medicine, Genetics and Human Reproduction, University Hospitals of Coimbra, 3000 Coimbra, Portugal 3In Vitro Fertilization
Unity, Pasteur Saint-Esprit Clinic, 29200 Brest, France 4Laboratorio FIV, Centro Hospitalar V.N. Gaia, 4400-129 V.N. Gaia, Portugal
5Department of Zoology and Anthropology, Faculty of Sciences, University of Oporto, and Centro de Estudos de Infertilidade e Esterilidade
(CEIE), 4050-345 Oporto, Portugal
6Correspondence address. Center for Neuroscience and Cell Biology, Department of Zoology, University of Coimbra, 3004-517 Coimbra,
Portugal. Tel:þ351-239-855-760; Fax: þ351-239-855-789; E-mail: jramalho@ci.uc.pt
table of contents
† Introduction
† Materials and Methods
† Results
† Discussion
† Author Roles
† Funding
† Acknowledgements
† References
background: Sperm chromatin status and nuclear DNA damage can be detected using well-established assays. However, most tech-
niques are time-consuming and/or involve elaborate protocols and equipment. We have recently developed a simple and fast method to
monitor sperm chromatin status in field conditions using the Diff-Quik assay which is employed in fertility clinics to assess sperm morphology
with standard bright field microscopy. In the present study, we demonstrate that any Diff-Quik-like stain can easily, reproducibly and routinely
monitor human sperm chromatin status as well.
methods: Different Diff-Quik-like stains were used to assess sperm morphology and the presence of abnormal dark nuclear staining in
human sperm from four ART centres. The TUNEL assay was performed in the same samples, and fertility outcomes were assessed.
results: A significant correlation was found between TUNEL-positive sperm and dark sperm nuclei. Moreover, associations were also
found between the percentage of dark sperm nuclei and seminal parameters, embryo development rate, embryo quality and clinical preg-
nancy, as well as with cryptorchidism, and there was a tendency towards an association with age. A value of 32% abnormal staining is
suggested as a predictive threshold for embryo development and pregnancy.
conclusions: Our results show that any Diff-Quik-like stain, already implemented in most laboratories to assess sperm morphology,
can be adapted as an indicator for chromatin status in human sperm.
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Introduction
Mounting evidence has shown that standard semen parameters
(sperm concentration, morphology and motility; WHO, 1999) do
not accurately predict fertility outcomes or the ability of sperm from
a given sample to fertilize an oocyte (Agarwal and Allamaneni,
2005), but merely indicate some degree of semen quality and the func-
tion of the male reproductive tract.
The role of a spermatozoon as a functional gamete is dependent on
many factors, such as the integrity of sperm nuclear DNA, which is
required for the correct transmission of paternal genetic information.
Several studies have indicated that there is a relationship between
sperm DNA integrity and fertility outcomes (reviewed in Agarwal
and Allamaneni, 2004; Sharma et al., 2004; O’Brien and Zini, 2005;
Spano et al., 2005; Li et al., 2006; Shamsi et al., 2008). Although the
possible relationship between sperm DNA damage and fertilization
rates remains controversial (Sun et al., 1997; Lopes et al., 1998;
Evenson et al., 2002; Henkel et al., 2004), it seems consensual that
a negative correlation between sperm DNA fragmentation and preg-
nancy rates and/or embryo development does exist (Seli et al.,
2004; Borini et al., 2006; Benchaib et al., 2007). Importantly, DNA
fragmentation has been pointed out as an important marker of male
infertility (Evenson et al., 2002; Bungum et al., 2004; Erenpreiss
et al., 2008), and infertile men seem to present significantly higher
levels of sperm DNA damage than fertile donors (Chohan et al.,
2006).
Sperm DNA damage has been detected using a variety of assays
(for review, see Evenson et al., 2002; Sharma et al., 2004; Agarwal
and Allamaneni, 2005), such as the sperm chromatin structure
assay (SCSA; Evenson et al., 1980), the acridine orange test
(Tejada et al., 1984), the single cell gel electrophoresis assay
(COMET; Aravindan et al., 1997), the in situ nick translation assay
(Gorczyca et al., 1993) and the terminal deoxynucleotidyl
transferase-mediated dUDP nick-end labelling assay (TUNEL; Sailer
et al., 1995). Using these assays, attempts have been made
towards establishing threshold values for the percentage of sperm
with damaged DNA, values above which fertility would be affected.
Ultimately, the assessment of sperm DNA status seems to be
important for a complete evaluation of sperm quality. However,
most of the techniques available are time-consuming and/or
involve elaborate protocols, reagents and equipment (e.g. fluor-
escence microscope and flow cytometer) that do not exist in stan-
dard andrology laboratories. Although specific cases may warrant
more detailed analysis, it is therefore unlikely that most laboratories
can introduce the assessment of sperm DNA status as a routine par-
ameter in semen evaluation (Perreault et al., 2003). Possible alterna-
tives to assess chromatin integrity involve colorimetric tests, either
directly on sperm with the use of dyes such as Toluidine Blue (Eren-
preiss et al., 2001) or Aniline Blue (Terquem and Dadoune, 1983) or
indirectly on sperm nuclear DNA, such as has been proposed with
the sperm chromatin dispersion test (Fernandez et al., 2003).
However, so far, these simpler methods have not been routinely
introduced, probably because these assays require specific stains
and other reagents that are not commonly present, or simply
because of the difficulty in implementing routine-altering procedures.
It is also important to note that the particular compacted nature of
sperm chromatin makes it difficult to assess to what degree the
defects monitored using the several assays described may also
depend on chromatin availability to bind and interact with the
several dyes and reagents involved in each case. In fact, an open
question remains as to whether what is being monitored using the
several assays described above is solely direct DNA damage or
changes in chromatin status, notably chromatin packing, which
would change DNA availability for reactions in the distinct protocols.
We have recently developed a simple and fast method to monitor
sperm DNA status for wild animals under field conditions (Mota and
Ramalho-Santos, 2006). This assay uses the Diff-Quik stain and is
based on the intensity of nuclear staining: normal sperm heads/
nuclei stain lightly, whereas heads/nuclei with fragmented/damaged
DNA present a darker stain. Although there are several commercial
Diff-Quik-like kits available, with different brand names, the protocol
always consists of methanol fixation, followed by sequential exposure
to eosin, an anionic/acid dye that stains positively charged/basic
proteins red, and a thiazin dye (often Methylene Blue or its oxidation
products, such as Azure B; or even a mix of several thiazins)
which stains DNA blue. The important issue is that this stain is
already widely used clinically to assess sperm morphology with stan-
dard bright field microscopy. In the present study, we demonstrate
that any Diff-Quik-like stain commonly used in Andrology labora-
tories to assess sperm morphology can also easily, reproducibly
and routinely serve to give an indication on the status, not necess-
arily of nuclear DNA, but, more broadly, of the chromatin in
human sperm.
Materials and Methods
All chemicals were from Sigma-Aldrich (St Louis, MO, USA), unless stated
otherwise. All patients signed informed consent forms, and all human
material was used in accordance with the appropriate ethical and internal
review board (IRB) guidelines provided by the participating institutions.
Biological material
Human sperm samples were obtained from the reproduction laboratories
of the University Hospitals of Coimbra, from the Pasteur Saint-Esprit clinic
in Brest, from CEIE in Oporto and from the Hospital Center of V.N. Gaia,
from patients undergoing routine semen analysis or fertility treatments
involving either in vitro fertilization (IVF) or intracytoplasmic sperm injec-
tion (ICSI). A total of 483 samples were collected and used in this
study: 364 for assessment of fertility outcome parameters and 119 for
optimization, and for comparisons with the TUNEL assay and between
stains. Fresh semen samples were obtained by masturbation after 2–5
days of abstinence and prepared as described earlier (Varum et al.,
2007). Seminal parameters, namely sperm concentration and sperm moti-
lity, were evaluated (WHO, 1999).
Fertility outcome parameters
A total of 364 cycles were included in this analysis. Fertility results from IVF
and ICSI cycles were evaluated (Table I). Fertilization rate (number of 2PN
oocytes/number of inseminated or injected oocytes) and embryo devel-
opment rate (number of embryos/number of inseminated or injected
oocytes) were calculated. Embryos were classified according to the
number, form and symmetry of blastomeres and the presence of blasto-
mere fragmentation, and were graded from I to IV as described (Elder
and Dale, 2000). Clinical pregnancy rate was also recorded.
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Diff-Quikw, Hemacolorw and Giemsaw assays
Both sperm morphology and staining features were assessed using three
different commercial kits: Diff-Quikw (Dade Behring Inc., Newark, NJ,
USA), Hemacolorw (Merck, Darmstadt, Germany) and Giemsaw
(Merck). Each of these Diff-Quik-like kits is composed of methanol (fixa-
tive), eosin (dye that stains basic proteins red) and by a thiazin-like stain
(which stains DNA blue). In the classic Giemsa kit, eosin and the thiazin
are mixed in the same solution, whereas in the two other kits the appli-
cation of each dye is sequential. Smears were prepared as previously
described (Mota and Ramalho-Santos, 2006). Briefly, 10 ml of a sperm
suspension was dragged with a coverslip and allowed to air dry. Slides
were then immersed, sequentially and for 10–20 s, in each kit solution,
and then rapidly dipped in water to remove excess dye. Slides were
allowed to air dry and were observed with a bright field microscope.
The staining characteristics were always analysed within each sample,
and two staining categories were established: sperm with light heads/
nuclei (normal staining) and sperm with dark heads/nuclei (abnormal
staining). In order to determine the percentage of dark sperm nuclei,
200 cells were counted per sample in four different fields. Sperm mor-
phology was assessed using strict criteria (Kruger et al., 1986). All assays
were done blindly and results were reproducible for three different
observers and on several optical microscopy setups. Following initial
studies, five more observers were trained, with consistent
reproducibility.
In addition to commercially available kits, the assay was also per-
formed using in-house prepared solutions. Accordingly, fixation was
carried out using 10%, 60% or 100% methanol, or 100% ethanol;
protein staining was performed using 0.1, 1, 5 or 10 g/l of eosin and
DNA staining was performed using 0.1, 1, 5 or 10 g/l solutions of
Methylene Blue, Azure A, Azure B or Toluidine Blue. Furthermore,
three sample exposure times (5, 10 or 20 s) to each solution were
used. In all cases, the percentage of abnormal dark sperm nuclei was
assessed, as previously described, and compared with results obtained
with the commercial Diff-Quik kit.
Positive controls for sperm chromatin
damage
Sperm samples were exposed to 50 U/ml deoxyribonuclease I (DNase I,
Ambion, Austin, TX, USA) for 10 min (to promote DNA fragmentation),
to 0.5% hydrogen peroxide (H2O2) overnight (to induce apoptosis) or to a
temperature of 758C for 5 min (to induce chromatin decondensation).
After each treatment, the Diff-Quik staining was performed as described
above, and the percentage of abnormal dark sperm nuclei was assessed.
TUNEL assay
DNA fragmentation was monitored using the APO-BrdU TUNEL assay kit
(Molecular Probes, Eugene, OR, USA), as previously described (Varum
et al., 2007). Briefly, 5  106 sperm/ml were fixed with 2% formaldehyde
in phosphate-buffered saline (PBS; pH ¼ 7.2) for 35 min, permeabilized in
PBS with 1% Triton X-100 for 15 min and washed with the washing buffer
provided. Samples were then incubated with a DNA labelling solution (10
ml of reaction buffer, 0.75 ml of TdT enzyme, 8.0 ml of BrdUTP and 31.25
ml of H2O) for 60 min at 378C. Cell suspensions were then washed in 200
ml of rinse buffer and cell pellets were incubated with Alexa Fluor 488 anti-
BrdU antibody (diluted 1:20 in rinse buffer) for 45 min in the dark at room
temperature. Sperm were counterstained with 4,6-diamino-2-phenylin-
dole (DAPI; Molecular Probes) and mounted in VectaShield mounting
medium (Vector Labs, Burlingame, CA, USA). Slides were observed
using a Zeiss Axioplan 2 Imaging fluorescence microscope (Carl Zeiss,
Go¨ttingen, Germany) equipped with a triple band-pass filter, and 200
sperm per sample were counted in four fields, by two independent
observers.
Statistical analysis
Statistical analysis was carried out using the SPSS version 13.0 software for
Windows (SPSS Inc., Chicago, IL, USA). All values are expressed as means
+ standard deviation (SD). The criterion of data normality was evaluated
using the Kolmogorov–Smirnov test. Pearson’s correlation coefficients (r)
and multiple linear regression (r2) analysis were performed to determine
the correlation and relationship of the results obtained with the three
different Diff-Quik-like kits, respectively, both for abnormal staining and
for morphology. Similar analyses were performed between the percen-
tages of dark sperm nuclei and TUNEL-positive sperm. A Bland–Altman
test (Bland and Altman, 1986) was also performed to check agreement
between the percentage of abnormal dark sperm nuclei and TUNEL-
positive sperm, using the Analyse-it software version 2.11. Comparisons
between stains were also carried out by paired samples t-test for the
mean percentages of morphologically normal sperm. Correlations
between abnormal staining and seminal parameters were also investigated.
As data of fertilization rate and embryo development rate do not present a
normal distribution, Spearman’s non-parametric correlation coefficient
test was performed to determine if there were any correlations with
abnormal staining. t-Test for equality of means was performed for
embryo quality, pregnancy outcome, male patient age and incidence of
cryptorchidism. Statistical relevance was considered when P , 0.05.
Results
The use of the Diff-Quikw, Hemacolorw and Giemsaw kits was opti-
mized as previously described for cat sperm (Mota and Ramalho-
Santos, 2006). Previous observations in this model system have
shown that controlled incubation of sperm samples in the Diff-Quikw
stain rendered most cell nuclei in the majority of samples lightly stained
(thus considered ‘normal’ staining), whereas some sperm depicted
darkly stained nuclei (thus considered ‘abnormal’ staining). The optim-
ization of each kit is mostly related with the incubation time needed in
each staining solution, which, in turn, is dependent of each observer’s
ability to discriminate sperm structures and may also vary with differ-
ent Diff-Quik-like kits. Exposure for short periods may not allow
enough contrast to properly distinguish sperm structures, whereas
long incubation periods (e.g. 1–5 min), especially in the solutions con-
taining thiazins, resulted in an uniform dark blue stain on all sperm
heads. Although sperm morphology could still easily be monitored
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Table I Mean percentages of clinical parameters,
including together data from all participating
institutions, in a total of 364 cycles*
Parameter Mean (%)
Fertilization rate 64.7
Embryo development rate 58.7
Transfer rate 83.0
Pregnancy rate 30.5
*Fertilization rate, number of 2PN oocytes/number of inseminated or injected oocytes;
embryo development rate, number of embryos/number of inseminated or injected
oocytes; transfer rate, number of cases transferred/number of cycles; pregnancy
rate, number of clinical pregnancies/number of transfers.
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under these conditions, cells with distinct staining hues could no longer
be identified. After establishing the optimal parameters for each kit,
the assay was very reproducible.
Sperm morphology was assessed with the three kits, in the same
samples, using the strict criteria (Kruger et al., 1986). Significant high
correlations (r) and relationships (r2) were found between the
results of different Diff-Quik-like stains (Table II). Furthermore,
there were no statistical differences between the mean percentages
of morphologically normal sperm detected using each assay (6.27
+ 4.8, 6.88 + 4.9 and 7.52 + 5.5, for Diff-Quik, Hemacolor and
Giemsa, respectively, P . 0.05; Fig. 1).
Whatever the assay used, the presence of lightly and darkly stained
sperm heads was observed in every sample (Fig. 2A and B, Table II).
Different combinations of staining kits, optical microscopes, lamp
intensities and camera settings were employed, resulting in different
background illuminations and sperm contrast (Fig. 2A and B).
However, the same samples gave similar percentages of abnormal
staining using different kits (Table II), and each of these individual set-
tings was always consistent. Following an initial experimental period,
the same conditions should be maintained for routine analysis. In
addition, sperm morphology values obtained using the dual-purpose
version of the stain were indistinguishable to those determined in par-
allel assays, in which only morphology was evaluated in the same
sample by an independent observer (data not shown). In order to
explore the possible variations that can exist between different com-
mercially available kits, different concentrations of fixative and of both
protein and DNA stains were used. Different compounds of the
thiazin family were also tested. Fixation with different concentrations
of methanol (10%, 60% and 100%) and ethanol (100%) was performed
and the results were compared with the results obtained with the fix-
ation solution included in the commercial Diff-Quik kit (60% metha-
nol). Similarly, protein staining with different eosin solutions (0.1–10
g/l) was performed and compared with the commercial Diff-Quik
kit. In both cases, results obtained with the different solutions were
indistinguishable from those obtained with the kit (data not shown),
suggesting that different concentrations of methanol or the use of
ethanol, or different concentrations of eosin, do not modify sperm
staining patterns.
For the theoretically more crucial process of DNA staining, we
tested different thiazins, such as Methylene Blue and its oxidation pro-
ducts, Azure A and Azure B, as well as another compound of the
thiazin family, Toluidine Blue. For all dyes, different concentrations
were used (0.1, 1, 5 and 10 g/l). Results obtained were similar what-
ever the thiazin solution used (data not shown). However, comparing
with the commercial Diff-Quik kit, the results obtained indicate that
the use of thiazin concentrations below 1 g/l causes a homogeneously
light sperm staining impairing the evaluation of the presence of both
normal and abnormal staining sperm. It should be noted that Toluidine
Blue was not used as has been described for the Toluidine Blue test
(Erenpreiss et al., 2001), but as a thiazin family compound that
could be part of a Diff-Quik-like kit, with a simpler protocol.
Using the commercially available Diff-Quik, we found that the per-
centage of dark sperm heads was highly and significantly correlated
with the proportion of sperm with damaged nuclear DNA, as moni-
tored using the TUNEL assay (TUNEL-positive sperm; Fig. 2C) (r ¼
0.681, r2 ¼ 0.464, P , 0.001; Fig. 3). Despite the existing correlation
between the proposed method and the TUNEL assay, Bland–Altman
analysis monitoring agreement between the two methods indicated
that they do not measure the same parameter. The mean difference
found was þ11.5 (meaning the average Diff-Quik measurement is
11.5% higher than a TUNEL measurement in the same sample), but
with limits from þ31.8 to 28.8, suggesting a wide variation. Given
that the two methods are not measuring exactly the same thing, posi-
tive controls were performed in order to understand what kind of
sperm chromatin impairments may be represented by dark sperm
nuclei. When sperm samples were submitted to DNase I, hydrogen
peroxide or excess heat, there was a statistically significant (P ¼
.................................................... ....................................................
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Table II Correlation coefficients (r) and relationships (r2) between the three Diff-Quik-like stains in human sperm in
terms of normal morphology (n 5 42) and abnormal staining (n 5 40)
Normal morphology Abnormal staining
Hemacolor Giemsa Hemacolor Giemsa
Diff-Quik r 0.658 0.810 0.833 0.849
r2 0.433 0.656 0.694 0.721
Giemsa r 0.634 0.847
r2 0.402 0.718
All values are statistically significant (P , 0.001).
Figure 1 Mean percentage of human sperm with normal mor-
phology assessed by each Diff-Quik-like stain, using strict criteria.
No statistical differences were found (P . 0.05) between the three kits.
Results represent the mean + SD in terms of percentage of cells, from 200
sperm observed for each sample (n ¼ 42).
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0.007, P ¼ 0.045 and P , 0.0001, respectively) increase in the
percentage of abnormal dark sperm nuclei (66.9 + 12.2%, 63.9 +
13% and 72.9 + 10%, respectively) compared with the control situ-
ation (54.8 + 11.2%) (Table III), especially for heat, suggesting that
chromatin availability to bind dyes may be the limiting factor.
Besides sperm morphology, other routine seminal parameters were
also assessed, such as sperm concentration and sperm motility (WHO,
1999). Significant negative correlations were found between the per-
centages of abnormal dark sperm nuclei and sperm concentration
(r ¼ 20.16, P , 0.05), progressive motility (r ¼ 20.16, P , 0.05)
and normal morphology (r ¼ 20.30, P , 0.0001).
Regarding the relationship between fertility outcome parameters
and sperm staining with Diff-Quik, there was a statistically significant
correlation between the percentage of dark sperm nuclei and
the embryo development rate (number of embryos/oocytes;
r ¼ 20.109, P ¼ 0.045); however, no correlation with fertilization
rate was found. On the other hand, there was a correlation with
embryo quality. Embryos were classified from Grades I to IV taking
into account the number, form and symmetry of blastomeres and
the presence of blastomere fragmentation (Elder and Dale, 2000).
Cases where all embryos were classified as Grade I were considered
as the ‘G1’ group, and cases where some or all embryos presented a
grade other than Grade I were included in the ‘other grade’ group
(Table IV). When we compared the mean percentage of abnormal
dark sperm nuclei from the two embryo quality groups, a significant
difference (P ¼ 0.047) was found, with the G1 group corresponding
to a lower mean percentage of sperm with abnormal dark nuclei
(60.18 + 19.4 and 64.68 + 19.8, respectively). In addition, clinical
pregnancies were also recorded and the mean percentage of abnormal
dark sperm nuclei from the pregnant and non-pregnant groups was
Figure 2 Human spermatozoa assessed for chromatin status.
(A and B) Diff-Quik-like assay with a standard bright field microscope. Using any of the three assays, spermatozoa with different staining intensities can be observed, which
include normal staining patterns (A), and sperm with abnormal dark staining heads (B). Note that different assays and microscope/camera settings can lead to different
backgrounds. (C) TUNEL assay, observed by fluorescence microscopy: sperm with DNA damage (TUNEL-positive sperm) present green fluorescence, and sperm with
intact DNA (TUNEL-negative sperm) are only labelled with the blue DAPI counterstain.
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Table III Comparison of mean percentage (+SD) of
dark sperm nuclei in samples subjected to induced
DNA/chromatin damage
Treatment Mean + SD P-value
Control 54.81 + 11.2
DNase I 66.88 + 12.2 0.007
H2O2 63.93 + 13 0.045
Heat 72.88 + 10 0.0001
Figure 3 Correlation between the percentage of TUNEL-positive
sperm and the proportion of sperm with dark heads/nuclei.
A significant high correlation was found (r ¼ 0.681; P , 0.001). The data fit the
linear regression curve: y ¼ 0.5514x þ 2.5977; r2 ¼ 0.464. Results represent
the percentage of cells from 200 sperm observed for each sample (n ¼ 42).
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compared (Table IV). There was a significant difference (P ¼ 0.027)
between the groups, with a lower mean percentage of sperm with
abnormal dark nuclei in the pregnant group (65.87 + 18.7 and
72.08 + 16.3, respectively).
Using the linear regression curve, we determined the cut-off values
corresponding to the TUNEL thresholds described in the literature
(Benchaib et al., 2003; Sergerie et al., 2005). Thus, the 20% threshold
assessed using the TUNEL assay correspond to a cut-off value of 32%
for abnormal staining, assessed using a Diff-Quik-like stain. Further-
more, a cut-off value of 32% for abnormal staining was indicative of
embryo development and pregnancy: for values above 32% of abnor-
mal dark sperm nuclei, there was a significant decrease in the embryo
development rate (71–58%, P , 0.05) and a decrease in the preg-
nancy rate of 2-fold (67–35%).
To assess a possible effect of age on sperm chromatin damage, we
divided our samples in order to obtain two groups with a similar
number of cases: a group with age ranging from 20 to 34 years old,
and a second group of patients aged 35 or older (Table IV). There
was a tendency for an increase in the percentage of sperm with abnor-
mal dark nuclei in the older group than in the younger group (61.10+
20 and 57.21 + 21.9, respectively); however, this increase was not
statistically significant (P ¼ 0.074).
Finally, at the Brest Centre, men involved in both IVF and ICSI cycles
answer a questionnaire that includes a mention of cryptorchidism
history, which has a high incidence in the region, possibly due to endo-
crine disruption (Phillips and Tanphaichitr, 2008). Of the 136 patients
from this clinic, 23 patients (16.9%) presented a history of cryptorch-
idism (Table IV), and that same group of cryptorchid patients showed
a significantly higher percentage of abnormal dark sperm nuclei than
the non-cryptorchid group (76.04+ 13.8 and 68.60+ 19.1, respect-
ively, P ¼ 0.034), in accordance with what has been described for this
condition (Stronati et al., 2006).
Discussion
Routine semen parameters are not able to assess sperm nuclear status
and men with abnormal sperm DNA may present normal
spermiograms (Alvarez, 2003; Agarwal and Allamaneni, 2004). Thus,
an important aspect of sperm status, certainly relevant to monitor
the status of male gametogenesis and reproductive tract, and with
possible influence on the outcome of ART, is not evaluated
(O’Brien and Zini, 2005; Spano et al., 2005; Li et al., 2006).
Several studies have used tests that purport to monitor DNA integ-
rity (Evenson et al., 2002; Fernandez et al., 2003; Sharma et al., 2004;
Agarwal and Allamaneni, 2005), although what is being monitored may
be more accurately defined as ‘chromatin status’ rather than ‘DNA
status’, since sperm chromatin compaction may affect the interactions
with DNA. Despite their possible clinical value, these techniques are
expensive, time-consuming and/or involve elaborate protocols,
reagents and equipment that are not available in most fertility clinics
or laboratories. Realistically, at least at an initial stage, recruitment
for large studies in several locations will have to rely on simple and
time-efficient methodology (Perreault et al., 2003). The present data
suggest a simple, inexpensive and fast method that assesses chromatin
status using, in essence, any Diff-Quik-like staining which is routinely
used to monitor sperm morphology.
A highly significant correlation was observed between sperm with
dark heads/nuclei, measured using a Diff-Quik-like stain, and sperm
with fragmented DNA, as detected using the TUNEL assay.
However, given that the percentage of abnormal dark sperm nuclei
obtained is always higher than the percentage of TUNEL-positive
sperm and that the two methods do not measure exactly the same
thing, it is important to understand what is being monitored. Thiazins
are DNA-binding dyes (unlike protein-binding dyes such as Aniline
Blue) and it is possible that changes in sperm chromatin, and thus
nuclear DNA, alter thiazin-DNA interactions, as is the case with the
acridine orange interaction with DNA in the SCSA assay. For
example, both breaks in DNA or changes in compaction could lead
to more dye-binding sites, thus increasing the percentage of darker
nuclei. Furthermore, as already noted, interaction depends on dye
accessibility to sperm DNA, which can vary greatly (Bungum et al.,
2007,2008), be donor-dependent (Erenpreiss et al., 2006) and even
be influenced by semen composition (Richthoff et al., 2002). Adding
to this accessibility hypothesis, results from positive controls described
to cause an increase in DNA fragmentation/chromatin decondensa-
tion (Sun et al., 1997; Lopes et al., 1998; Varum et al., 2007), i.e. an
increase in DNA accessibility, showed significant increase in the per-
centage of abnormal dark sperm nuclei. Overall, these data suggest
that an increase in the percentage of abnormal staining is primarily
indicating an increase in dye access to sperm DNA, and thus
nuclear damage in the form of a less compacted state likely including,
but not exclusively, DNA fragmentation.
As mentioned, this assay is already implemented, in some form, in
most laboratories, and different versions give similar results. Given that
in most samples analysed, a high percentage of sperm (.40%) was
lightly coloured (i.e. ‘normal’), with minimal optimization it would be
possible to routinely have at least some evaluation of sperm chromatin
status and assess its true importance as a marker of male infertility
using a Diff-Quik-like stain. Furthermore, sperm morphology can
also be easily and simultaneously monitored.
Interestingly there are several relationships between outcome par-
ameters and chromatin status, as assessed using Diff-Quik-like stains.
Our results indicate that there is no correlation between abnormal
staining and the fertilization rate. Although this finding is contrary to
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Table IV Comparison between the groups according
to embryo quality (good quality embryos, ‘G1’, and
poor quality embryos, ‘other grade’), clinical
pregnancy, male age and cryptorchidism incidence
Parameters Groups Mean +
SD
P-value
Embryo quality G1 60.18 + 19.4 0.047
Other grade 64.68 + 19.8
Clinical pregnancies Yes 65.87 + 18.7 0.027
No 72.08 + 16.3
Age 20–34 57.21 + 21.9 0.074
35 61.10 + 20
Cryptorchidism
incidence
Cryptorchid 76.04 + 13.8 0.034
Non-cryptorchid 68.60 + 19.1
Values are mean percentages (+SD) of dark sperm nuclei assessed using a
Diff-Quik-like stain.
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some studies (Sun et al., 1997; Lopes et al., 1998; Benchaib et al., 2007;
Velez de la Calle et al., 2007), it is in accordance with the majority (Host
et al., 2000; Larson-Cook et al., 2003; Henkel et al., 2004; Lin et al.,
2008). Since the paternal genome is only activated 2 days after fertiliza-
tion (Braude et al., 1988), the status of sperm DNA may not dramati-
cally influence fertilization. However, and confirming previous findings
from several other groups, there was an association between the per-
centage of dark sperm nuclei and the embryo development rate
(Morris et al., 2002; Tesarik et al., 2004), suggesting that the presence
of higher levels of sperm chromatin damage might impair embryo devel-
opment. Similarly, when the influence of sperm chromatin status on
embryo quality was analysed, we determined that good quality
embryos are associated with a lower mean percentage of sperm with
damaged DNA, in accordance with other data (Zini et al., 2005;
Velez de la Calle et al., 2007). Finally, the establishment of a clinical preg-
nancy was associated with a lower mean percentage of sperm with
abnormal dark nuclei; these results are in accordance with several
studies, where relationships between sperm DNA integrity and preg-
nancy are described (Tomlinson et al., 2001; Benchaib et al., 2003;
Henkel et al., 2003; Larson-Cook et al., 2003).
In conjunction with male infertility problems, other factors have
been associated with an increase in sperm DNA damage. In our popu-
lation, there was a tendency for an increase in the percentage of
sperm with abnormal dark nuclei in men aged 35 or older. Moreover,
as has been recently described (Smith et al., 2007; Velez de la Calle
et al., 2007), levels of sperm chromatin damage are significantly
higher in cryptorchid subjects.
The assay described here could be useful in large-scale studies asses-
sing sperm chromatin status, such as those concerning the impact of
environmental factors on sperm integrity in human populations (Bian
et al., 2004; Stronati et al., 2006; Long et al., 2007). Indeed, it could
even be carried out in field conditions, as is currently the case for
wild carnivores (Mota and Ramalho-Santos, unpublished data).
Several thresholds for sperm DNA or chromatin integrity have been
proposed, in terms of their possible predictive power in ART pro-
cedures. For example, a 20% or above threshold for TUNEL-positive
sperm in a sample has been proposed to distinguish fertile from infer-
tile men (Sergerie et al., 2005), and thus define a value above which
pregnancy is unlikely to occur (Benchaib et al., 2003). This value math-
ematically corresponds to a cut-off value of 32% of abnormally
stained sperm. Interestingly, when this value is used as a threshold
for our method, there are strong indications in terms of embryo devel-
opment and pregnancy. This threshold is quite similar to the threshold
suggested for SCSA (DFI . 30%; Evenson et al., 2002; Bungum et al.,
2007), possibly due to the fact that, as for SCSA, the Diff-Quik-like kits
measure DNA accessibility, which may include both DNA fragmenta-
tion and chromatin decondensation.
It is clear that several aspects will need to be validated by further work.
An important issue relates to the fact that all optical microscopy obser-
vations can have some degree of subjectivity, especially with the pressure
toproduce timely analyses. Evenwith assays such asTUNEL, proper train-
ing is necessary to distinguish ‘bona fide’ staining fromnon-specific speckl-
ing. But, once this is established, direct comparisons of TUNEL results
using fluorescence microscopy and ‘blind’ flow cytometry in the same
samples show complete consistency (Varum et al., 2007).
In summary, the present study shows that by using a Diff-Quik-like
stain, it would be possible to routinely evaluate chromatin status in
human sperm, whether it is related to direct DNA damage or DNA
compaction, and assess its true importance as a marker of male infer-
tility. The assay is already implemented, in some form, in most labora-
tories to assess sperm morphology.
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